Abstract:Background and objectives: Clinical trials developing therapeutics for frontotemporal degeneration (FTD) focus on pathogenic variant carriers at preclinical stages. Objective, quantitative clinical assessment tools are needed to track stability and delayed disease onset. Natural speech can serve as an accessible, cost-effective assessment tool. We aimed to identify early changes in the natural speech of FTD pathogenic variant carriers before they become symptomatic. Methods: In this cohort study, speech samples of picture descriptions were collected longitudinally from healthy participants in observational studies at the University of Pennsylvania and Columbia University between 2007 and 2020. Participants were asymptomatic but at risk for familial FTD. Status as "carrier" or "noncarrier" was based on screening for known pathogenic variants in the participant's family. Thirty previously validated digital speech measures derived from automatic speech processing pipelines were selected a priori based on previous studies in patients with FTD and compared between asymptomatic carriers and noncarriers cross-sectionally and longitudinally. Results: A total of 105 participants, all asymptomatic, included 41 carriers: 12 men [30%], mean age 43 ± 13 years; education, 16 ± 2 years; MMSE 29 ± 1; and 64 noncarriers: 27 men [42%]; mean age, 48 ± 14 years; education, 15 ± 3 years; MMSE 29 ± 1. We identified 4 speech measures that differed between carriers and noncarriers at baseline: mean speech segment duration (mean difference -0.28 seconds, 95% CI -0.55 to -0.02, p = 0.04); word frequency (mean difference 0.07, 95% CI 0.008-0.14, p = 0.03); word ambiguity (mean difference 0.02, 95% CI 0.0008-0.05, p = 0.04); and interjection count per 100 words (mean difference 0.33, 95% CI 0.07-0.59, p = 0.01). Three speech measures deteriorated over time in carriers only: particle count per 100 words per month (β = -0.02, 95% CI -0.03 to -0.004, p = 0.009); total narrative production time in seconds per month (β = -0.24, 95% CI -0.37 to -0.12, p < 0.001); and total number of words per month (β = -0.48, 95% CI -0.78 to -0.19, p = 0.002) including in 3 carriers who later converted to symptomatic disease. Discussion: Using automatic processing pipelines, we identified early changes in the natural speech of FTD pathogenic variant carriers in the presymptomatic stage. These findings highlight the potential utility of natural speech as a digital clinical outcome assessment tool in FTD, where objective and quantifiable measures for abnormal behavior and language are lacking.

Classification of Manifest Huntington Disease using Vowel Distortion Measures

Digital assessment of speech in Huntington disease

Vocal markers from sustained phonation in Huntington's Disease

Language-Independent Acoustic Biomarkers for Quantifying Speech Impairment in Huntington's Disease

Graph Methods to Infer Spatial Disturbances: Application to Huntington's Disease's Speech

Automated Huntington's Disease Prognosis via Biomedical Signals and Shallow Machine Learning

Brain Volumetric Analysis Using Artificial Intelligence Software in Premanifest Huntington's Disease Individuals from a Colombian Caribbean Population

Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review

Speech signal analysis as an aid to clinical diagnosis and assessment of mental health disorders

Verbal fluency in Huntington’s disease: a longitudinal analysis of phonemic and semantic clustering and switching

Linking White Matter and Deep Gray Matter Alterations in Premanifest Huntington Disease.

Language-Independent Approach for Automatic Computation of Vowel Articulation Features in Dysarthric Speech Assessment

Artificial intelligence classifies primary progressive aphasia from connected speech

Multiparametric characterization of white matter alterations in early stage Huntington disease

Task-voting for schizophrenia spectrum disorders prediction using machine learning across linguistic feature domains

Bulbar ALS Detection Based on Analysis of Voice Perturbation and Vibrato

Detection of Mild Cognitive Impairment From Non-Semantic, Acoustic Voice Features: The Framingham Heart Study

Changes in Digital Speech Measures in Asymptomatic Carriers of Pathogenic Variants Associated With Frontotemporal Degeneration

Using sustained vowels to identify patients with mild Parkinson's disease in a Chinese dataset

A Study on Voice Measures in Patients with Parkinson's Disease

Automated free speech analysis reveals distinct markers of Alzheimer's and frontotemporal dementia